Our Mission is to strive towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine.
We serve the needs of our patients, wherever they are. We earn the trust of society and customers through Takeda-ism.
Our Strategic Roadmap has four pillars which lay out the steps to achieving Vision 2025. We will focus on Values, People, R&D, and Business Performance as they will help us to progress toward Vision 2025. They need to be reviewed regularly to track progress and make sure we stay on the path to Vision 2025.
We set clear goals, plans and KPIs to serve the needs of our patients, wherever they are, and to earn the trust of society and our customers.
Takeda has an unwavering commitment to patients and is building a patient-centric and customer-centric organization. Our local organizations are empowered to respond in the best way to meet patient and customer needs.
Our employees are the cornerstone of our success. We create a diverse, inclusive, safe, open and collaborative working environment where employees can contribute, perform and grow as individuals.
Takeda leaders demonstrate strategic thinking, find innovative ways to serve patients, build trust with society, reinforce our reputation, and grow the business. They create an environment that inspires and enables people to collaborate and move the organization forward. They focus on our few designated priorities and deliver superior results. And they elevate the capabilities of our organization for today and the future.
Takeda has a world-class R&D engine, making an impact on patients’ lives by translating science into life-changing medicines.
As an R&D-driven company, we focus our research efforts where we want to be at the cutting edge of innovation. We have research centers focusing on four core therapy areas of Oncology, Gastroenterology (GI), Rare Diseases and Neuroscience.
Our productive R&D engine uses a combined approach of internal and external innovation to deliver a sustainable pipeline. We also have the ambition to be among the best partners in the industry.
Date of Preparation: March 2021